Thermis Chikungunya Vaccine Enters Phase III Trials- Major Breakthrough

Like
Like Love Haha Wow Sad Angry

Themis’s Vaccine for Chikungunya raises €40M in Series D round. In one of the most extensive Series D Round for Biotech at Australia, Themis Biosciences was successful in raising €40M to fund the Phase III trials for its Chikungunya Vaccine. This round was co-led investors like Farallon Capital and Hadean Ventures, Adjuvant Capital, aws Gründerfonds, Omnes […]

The post Thermis Chikungunya Vaccine Enters Phase III Trials- Major Breakthrough appeared first on BioTecNika .Read more at  www.biotecnika.org/2019/09/thermis-chikungunya-vaccine-enters-phase-iii-trials-major-breakthrough/

Like
Like Love Haha Wow Sad Angry